Vivera is an innovative, science-driven pharmaceutical company focused on novel therapies for a variety of indications. In addition to its pharmaceutical, medical device, advanced diagnostics, medical supply, medical technologies, neurosciences, and health and human service divisions, the Company has global exclusivity to license the patented and patent-pending TABMELT®️ sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds. Vivera is vertically integrated with technology, manufacturing capabilities, and distribution for its products.
Vivera is committed to continued research and development of innovative non-addictive pain management products. We believe that now is the time to combat some of the most serious problems affecting patients, physicians, and caregivers, including safe pain management and opiate cessation and deterrence programs. Through its non-profit platform, Vivera Cares, Vivera intends to extend the same mission to its local and global community.
Vivera is committed to making a positive difference in our local and global communities. Through our non-profit, Vivera Cares, we assist those who need it most. This includes helping underserved communities like Tribal Nations and frontline health care workers access valuable resources like COVID-19 testing and medical supplies.
NEWPORT BEACH, Calif., Feb. 25, 2021 /PRNewswire/ — Vivera Pharmaceuticals, Inc., is pleased to announce the expansion of its exclusive global licensing of the novel
NEWPORT BEACH, Calif., Jan. 25, 2021 /PRNewswire/ — Vivera Pharmaceuticals, in partnership with Burkhan Group, is excited to announce a new testing initiative in Southern
NEWPORT BEACH, Calif., Nov. 25, 2020 /PRNewswire/ — Vivera Pharmaceuticals and Burkhan World today announce financial backing by JR Dallas Wealth Management in support of
NEWPORT BEACH, Calif., Nov. 24, 2020 /PRNewswire/ — Vivera Pharmaceuticals is pleased to announce the appointment of Dr. Gerald A. Maguire, Professor and Chair of
NEWPORT BEACH, Calif., Nov. 18, 2020 /PRNewswire/ — Vivera Pharmaceuticals is excited to announce a distribution partnership with EcoGroup USA for Vivera’s BioZone, an advanced
NEWPORT BEACH, Calif., Oct. 7, 2020 /PRNewswire/ — Vivera Pharmaceuticals has been selected by Pure Health, the largest laboratory network in the UAE, to test
Innovation is the lifeblood of Vivera. With six divisions, each focused on a specific crisis response, Vivera’s vertically integrated structure has created an agile and responsive model.
Vivera is changing the future of drug delivery across the globe with its intellectual property portfolio.
Copyright © 2021 Vivera Pharmaceuticals, Inc. All rights reserved.
This information – including product information – is intended only for certified clinicians in the United States. The products discussed herein may have different labeling in different countries. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
English
Arabic
Armenian
Chinese (Simplified)
Chinese (Traditional)
Czech
Dutch
Filipino
French
Frisian
German
Irish
Italian
Korean
Persian
Portuguese
Russian
Spanish
Swedish
Vietnamese